Screener
Ligand Pharmaceuticals LGND Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $6.33B.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's market capitalization?
- Ligand Pharmaceuticals (LGND) reported market capitalization of $6.33B in Q2 2026.
- How has Ligand Pharmaceuticals's market capitalization changed year-over-year?
- Ligand Pharmaceuticals's market capitalization increased by 177.7% year-over-year, from $2.28B to $6.33B.
- What is the long-term trend for Ligand Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's market capitalization has grown at a 17.5% compound annual growth rate (CAGR), from $1.66B to $3.72B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Ligand Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude